TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA
Delisted
TBRA was delisted on the 31st of October, 2016.
41 hedge funds and large institutions have $4.89M invested in Tobira Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
41
Holding in Top 10
–
Calls
$3K
Puts
$3K
Top Buyers
| 1 | +$834K | |
| 2 | +$56.6K | |
| 3 | +$37.8K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.8K |
| 5 |
Morgan Stanley
New York
|
+$35.2K |
Top Sellers
| 1 | -$693K | |
| 2 | -$143K | |
| 3 | -$114K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$69K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$47K |